AVDL
Marshall Wace’s Avadel Pharmaceuticals AVDL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-314,343
| Closed | -$2.46M | – | 2539 |
|
|
2025
Q1 | $2.46M | Buy |
+314,343
| New | +$2.46M | ﹤0.01% | 1296 |
|
|
2024
Q4 | – | Sell |
-195,892
| Closed | -$2.57M | – | 2380 |
|
|
2024
Q3 | $2.57M | Buy |
+195,892
| New | +$2.57M | ﹤0.01% | 1180 |
|
|
2024
Q2 | – | Sell |
-383,641
| Closed | -$6.48M | – | 2298 |
|
|
2024
Q1 | $6.48M | Buy |
383,641
+229,056
| +148% | +$3.87M | 0.01% | 785 |
|
|
2023
Q4 | $2.18M | Sell |
154,585
-306,218
| -66% | -$4.32M | ﹤0.01% | 986 |
|
|
2023
Q3 | $4.75M | Sell |
460,803
-148,223
| -24% | -$1.53M | 0.01% | 789 |
|
|
2023
Q2 | $10M | Buy |
609,026
+301,151
| +98% | +$4.96M | 0.02% | 632 |
|
|
2023
Q1 | $2.82M | Buy |
+307,875
| New | +$2.82M | 0.01% | 1037 |
|
|
2022
Q3 | – | Sell |
-11,081
| Closed | -$27K | – | 2547 |
|
|
2022
Q2 | $27K | Sell |
11,081
-82,046
| -88% | -$200K | ﹤0.01% | 2614 |
|
|
2022
Q1 | $636K | Buy |
+93,127
| New | +$636K | ﹤0.01% | 2021 |
|
|
2020
Q4 | – | Sell |
-131,270
| Closed | -$661K | – | 1730 |
|
|
2020
Q3 | $661K | Buy |
+131,270
| New | +$661K | ﹤0.01% | 1123 |
|
|
2015
Q1 | – | Sell |
-275,983
| Closed | -$4.73M | – | 793 |
|
|
2014
Q4 | $4.73M | Buy |
275,983
+161,656
| +141% | +$2.77M | 0.06% | 319 |
|
|
2014
Q3 | $1.64M | Buy |
+114,327
| New | +$1.64M | 0.02% | 478 |
|